Latest News Release

Corporate Update

Announces Filing Of Its Initial Annual Information Form And Eligibility Under The Prompt Offering Qualification System

Provides Taped Conference Call Regarding Today’s Announcement For Licensing Agreement For Veterinary Use

Enters Agreement With Pfizer Inc.

Reports Third Quarter Results

Announces Results Of Reolysis® Treatment Of Brain Tumors In nimal Models

Receives Second U.S. Patent Approval

Presents Canine Pilot Study Results At The Veterinary Cancer Society Conference


Year

Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas Read More

Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic Breast Cancer Read More

View all news articles

Exploring REOLYSIN®’s Objective Response Rate in Females with Colorectal Cancer Read More

Exploring REOLYSIN<sup>®</sup>’s Objective Response Rate in Females with Colorectal Cancer thumbail
View all blog posts

LATEST TWEETS

Sorry, there was a problem. Twitter returned the following error message:

Could not authenticate you.

Follow us on Twitter